DPC Supports Increased Access and Quality of Care for Dialysis Patients Amid COVID-19

2020-04-02T14:09:49+00:00March 23rd, 2020|Categories: Care Coordination, Comment Letter, Increase Quality of Care, Medicare Advantage, Transportation Services, Treatment Options|Tags: |

DPC provided feedback to the U.S. Department of Health and Human Services (HHS) regarding the COVID-19-related issues that the kidney community is facing. DPC made recommendations to HHS in the following areas: Transportation COVID-19 Treatments and Vaccinations Home Dialysis People with End-Stage Renal Disease have a higher risk for developing a severe illness from COVID-19. As a result, it is crucial we do all that we can to help this vulnerable population in order to decrease the negative impact and spread of the virus. Read DPC's letter to HHS below for more details: Kumiko Lippold, PhD, MPH Department of Health [...]

DPC Comments on CMS Proposed Rule Regarding Medicare Advantage

2020-03-31T19:36:28+00:00March 10th, 2020|Categories: Care Coordination, Comment Letter, Medicare Advantage, Treatment Options|

In 2021 End-Stage Renal Disease (ESRD) patients will be permitted to enroll in Medicare Advantage (MA) plans, potentially bringing major changes to ESRD care and how patients experience it. When open enrollment begins this fall, we want to make sure patients have access to the same robust benefits offered with MA plans right now. DPC reached out to the Centers for Medicare & Medicaid Services (CMS) with recommendations on how to ensure ESRD patients maintain the access, choice and quality care they expect when these benefits are available to everyone. Currently, the only ESRD patients with MA plans are those [...]

Congress Comments on CMS Proposed Rule Regarding ESRD Treatment Choices Model Demonstration

2020-03-21T20:41:19+00:00October 18th, 2019|Categories: Access to Transplant, Care Coordination, Comment Letter, News, Treatment Options|

This month Members of Congress reached out to the Centers for Medicare and Medicaid Services (CMS) about the ETC Model, which is the same rule DPC commented on last month that pertains to increasing the number of home dialysis treatments and kidney transplants. In the letter, lawmakers raised concerns that parallel many of the priorities DPC advocates for in order to improve dialysis patient care. Specifically, the letter addressed: Improving access to care and treatment options Promoting patient choice Advancing care coordination Increasing access to transplant With over 70 signatures from legislators supporting the letter, we are pleased to see that [...]

DPC Comments on CMS Proposed ESRD Annual Payment Rule to Improve Dialysis Patient Quality of Life

2020-03-21T20:41:19+00:00October 11th, 2019|Categories: Access to Transplant, Article, Charitable Premium Assistance, Comment Letter, Dental Coverage, Dialysis Funding, Innovation, Medicare Advantage, Quality Incentive Program, Treatment Options|

Each year—typically during the summer—the Centers for Medicare and Medicaid Services (CMS) puts out rules for how they are going to pay for dialysis treatment. The rules reflect CMS' latest policies, and organizations have the opportunity to provide feedback about the rules before they go into effect on January 1. DPC provided feedback to CMS regarding their end-stage renal disease (ESRD) Annual Payment rule. DPC's letter addresses the following important topics for improving ESRD patient care: Transitional Add-On Payment Adjustment for New and Innovative Equipment and Supplies Anemia Management Social Risk Factors and their Impact on the QIP The Need [...]

DPC Comments on CMS Proposed Rule Regarding ESRD Treatment Choices Model Demonstration

2020-03-21T20:41:19+00:00September 4th, 2019|Categories: Access to Transplant, Comment Letter, Dental Coverage, Innovation, Medicaid, Transplant Donor Protection, Treatment Options|

In response to the Administration's announcement to improve kidney health in America, the Centers for Medicare and Medicaid Services (CMS) proposed a rule to implement a mandatory Medicare payment model designed to increase the number of home dialysis treatments and kidney transplants, all while reducing Medicare expenditures. The rule—referred to as the End-Stage Renal Disease (ESRD) Treatment Choices Model (ETC Model)—would measure clinician and facility performance, as well as the rate of home dialysis and kidney transplants in selected geographic regions. These calculations would result in either an increase or decrease of Medicare funding to a particular facility or clinician, [...]

DPC’s Letter to the California Assembly About Quality Ratings

2020-03-21T20:41:50+00:00April 23rd, 2019|Categories: 5-Star Ratings, Comment Letter|

Assembly Member Jim Wood Chair Committee on Health State Capitol, Room 6005 Sacramento, CA 95814 Assembly Member Chad Mayes Vice Chair Committee on Health State Capitol, Room 6005 Sacramento, CA 95814 Re: Support for AB 1448 Dear Chairman Wood and Vice Chairman Mayes: With 32,000 dialysis patient members, over 4,000 of whom reside in California, Dialysis Patient Citizens (DPC) is the nation’s largest patient-led organization representing individuals with end-stage renal disease (ESRD).  On behalf of California’s 70,000 ESRD patients and the DPC Board of Directors, I am writing to express our strong support for [...]

DPC Comments on Threat to Vascular Access Centers

2020-03-21T20:42:26+00:00September 19th, 2018|Categories: Article, Comment Letter, Dialysis Funding, Improve Access to Care|

The Centers for Medicaid Services (CMS) is proposing to cut reimbursement for vascular access centers. This could negatively impact dialysis patents’ access to care, which is why we have weighed in on this important issue. Dialysis Access and Fistulas People with kidney failure need to have a dialysis access placed in order to receive live-saving dialysis treatments. Vascular surgeons create and maintain arteriovenous fistulas, which is a type of dialysis access. Fistulas are important for individuals on dialysis as they are considered a best practice in kidney care, improve patient outcomes and reduce the risk of infection. Read DPC’s comment letter [...]

DPC Comments on Annual Medicare ESRD Rule

2020-03-21T20:42:26+00:00August 29th, 2018|Categories: Comment Letter, Innovation, Quality Incentive Program|

Dialysis Patient Citizens sent its comment letter to the Centers for Medicare & Medicaid Services (CMS) expressing concerns and providing feedback on its End-Stage Renal Disease Prospective Payment System and Quality Incentive Program proposed payment rule (CMS-1691-P). The letter was informed by results from Dialysis Patient Citizen’s 2018 membership survey and focused on the following areas: Quality incentive program and the meaningful measures framework Transitional drug add-on payment adjustment and payments to reward innovation Request for information on price transparency Our hope is that by addressing these important topics, CMS will make amendments to the rule that will ultimately lead [...]

DPC Supports Improved Access to Private Insurance for Patients

2020-03-21T20:42:26+00:00August 22nd, 2018|Categories: Access to Transplant, Article, Comment Letter, Dental Coverage|Tags: |

Currently, dialysis patients are restricted to 30 months on private insurance coverage before having to go into Medicare. The House of Representatives recently proposed extending this length of time by three months, which is estimated to save Medicare $344 million. Access to private insurance is critical for dialysis patients, and we are very appreciative of the House’s efforts to improve that access. Read our letter below in support of this proposal: Dear Leader McConnell, Minority Leader Schumer, Chairman Hatch, and Ranking Member Wyden: As America’s largest patient-led kidney disease organization representing over 30,000 dialysis patients and family members, Dialysis Patient [...]

DPC Submits Comments on Market Stabilization

2020-03-21T20:43:09+00:00March 9th, 2017|Categories: Comment Letter, Transportation Services|

A recent proposed rule released by the Centers for Medicare & Medicaid Services (CMS) provided guidance for market stabilization of the Affordable Care Act.  Within this proposed rule, network adequacy provisions for dialysis clinics provided a narrow scope for insurers. In comments submitted by DPC on March 6, we argued stronger time and distance criteria need to be added to these provisions. Research shows there is little difference between living in a metropolitan area compared to living in a rural environment, but there are significant mortality risks associated with actual distance from a dialysis facility. Additionally, after only 15 minutes of [...]

Go to Top